Comparing the expression of DDR1 gene in various tumor models revealed DDR1 to be elevated in all tumors with maximal expression in brain cancers, low-grade gliomas (LGG), and GBM (Figure 5C) [source: GEPIA; datasets, TCGA (tumor), GTEx (Normal)]. This evidence concerns the gene DDR1 and central nervous system cancer.